Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000221017 | SCV000273325 | likely benign | Hereditary cancer-predisposing syndrome | 2020-09-18 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Color Diagnostics, |
RCV000221017 | SCV000906778 | likely benign | Hereditary cancer-predisposing syndrome | 2016-08-31 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001454607 | SCV001658339 | likely benign | Ataxia-telangiectasia syndrome | 2024-05-29 | criteria provided, single submitter | clinical testing | |
Myriad Genetics, |
RCV004589919 | SCV005085548 | likely benign | Familial cancer of breast | 2024-05-17 | criteria provided, single submitter | clinical testing | This variant is considered likely benign. This variant is intronic and is not expected to impact mRNA splicing. |
Quest Diagnostics Nichols Institute San Juan Capistrano | RCV004998443 | SCV005624223 | uncertain significance | not provided | 2024-01-15 | criteria provided, single submitter | clinical testing |